GO:0055014 atrial cardiac muscle cell development: Chamber Specification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055014 describes the progression of an atrial cardiac muscle cell from its formation to its mature state, including the acquisition of atrial-specific structural, electrical, and secretory properties.
• Atrial cardiomyocytes are distinct from ventricular cells in gene expression, electrophysiology, and endocrine function, and single-cell transcriptomics has resolved chamber-specific cell populations in the human heart.
• Key atrial identity genes include TBX5, NR2F2, PITX2, NPPA, NPPB, MYH6, and KCNJ3, whose coordinated expression underlies atrial contraction, relaxation, and natriuretic peptide secretion.
• Disruption of atrial cardiomyocyte development and maintenance contributes to atrial fibrillation, atrial remodeling, and arrhythmogenesis through electrical, structural, and inflammatory mechanisms.
• Human induced pluripotent stem cell-derived atrial cardiomyocytes provide a tractable model to study atrial development, disease mechanisms, and antiarrhythmic drug responses.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate atrial genes in relevant cellular and animal systems.
Description
Atrial cardiac muscle cell development (GO:0055014) is the biological process by which atrial cardiomyocytes progress from their formation to a mature state, acquiring the structural, electrical, and secretory features that distinguish them from ventricular cardiomyocytes. The atrium is the blood-receiving chamber of the heart, and its muscle cells are striated, contractile cells responsible for pumping blood into the ventricle; their development is therefore central to normal cardiac function. Recent single-cell and spatial transcriptomic studies have revealed substantial transcriptional and cellular diversity within the human heart, including chamber-specific cardiomyocyte populations that reflect distinct developmental programs. Understanding how atrial cardiomyocytes are specified, mature, and maintained is essential for deciphering the origins of atrial arrhythmias and for developing chamber-selective therapeutic strategies. The process encompasses early chamber specification, sarcomeric assembly, ion channel maturation, metabolic specialization, and the establishment of endocrine functions such as natriuretic peptide secretion. Disruption of these steps can lead to atrial remodeling, conduction abnormalities, and increased susceptibility to atrial fibrillation, the most common sustained arrhythmia in clinical practice. Human induced pluripotent stem cell-derived atrial cardiomyocytes have emerged as a powerful platform to model atrial development and disease, and to test antiarrhythmic interventions in a chamber-specific context. Because atrial and ventricular cardiomyocytes share many core cardiac genes but differ in chamber-specific transcription factors and ion channel profiles, precise genetic tools are required to dissect the causal contribution of individual genes to atrial development and disease. This article integrates the QuickGO definition of GO:0055014 with verified PubMed literature to summarize the mechanisms, key genes, disease links, and research methods relevant to atrial cardiac muscle cell development.
atrial cardiac muscle cell development At A Glance
| GO ID | GO:0055014 |
|---|---|
| GO term | atrial cardiac muscle cell development |
| Ontology | biological_process |
| Synonym | atrial cardiomyocyte development; atrial heart muscle development |
| Major function | Progression of atrial cardiac muscle cells from formation to mature state, enabling atrial contraction and endocrine function |
| Related chamber | Atrium, the blood-receiving chamber of the heart |
| Key cell type | Atrial cardiomyocyte, a striated contractile cell |
| Representative markers | NPPA, NPPB, MYH6, TBX5, NR2F2, PITX2 |
| Disease relevance | Atrial fibrillation, atrial remodeling, arrhythmogenesis |
What Is GO:0055014?
GO:0055014, atrial cardiac muscle cell development, is defined as the process whose specific outcome is the progression of an atrial cardiac muscle cell over time, from its formation to the mature state. Cardiac muscle cells are striated muscle cells responsible for heart contraction, and the atrium is the part of the heart that receives blood into the organ. In practical terms, this GO term covers the developmental trajectory of atrial cardiomyocytes, including their specification within the atrial chamber, morphological and functional maturation, and acquisition of atrial-specific physiological properties.
Why Is atrial cardiac muscle cell development Important in Cell Biology?
Atrial cardiac muscle cell development is important because the atrium initiates ventricular filling and contributes endocrine signals that regulate blood volume and pressure; defects in atrial cardiomyocyte specification or maturation can produce chamber-specific arrhythmias, structural remodeling, and heart failure. Because atrial and ventricular cardiomyocytes differ in gene expression and electrophysiology, understanding GO:0055014 is essential for developing atrial-selective therapies that avoid ventricular side effects.
• Defines the developmental program that establishes atrial chamber identity and function.
• Underpins atrial contraction and relaxation, which are required for efficient ventricular filling.
• Controls secretion of natriuretic peptides (NPPA, NPPB) that regulate blood volume and pressure.
• Determines atrial-specific ion channel expression and action potential properties.
• Disruption is linked to atrial fibrillation and electrical remodeling.
• Inflammatory and lipid signaling pathways can modulate atrial remodeling and arrhythmogenesis.
• Structural proteins such as obscurin contribute to atrial calcium handling and arrhythmia susceptibility.
• Single-cell transcriptomics has revealed chamber-specific cardiomyocyte diversity relevant to development.
• Human iPSC-derived atrial cardiomyocytes enable disease modeling and drug testing.
• CRISPR-based models allow causal testing of atrial genes in development and disease.
What Happens During atrial cardiac muscle cell development?
Chamber specification and early atrial identity
In simple terms: Early in development, cells in the heart tube are told to become atrial cells rather than ventricular cells.
Atrial cardiac muscle cell development begins with the specification of atrial identity within the developing heart, a process governed by chamber-specific transcription factors and signaling cues. Recent insights into atrial chamber formation highlight the interplay of conserved transcriptional networks that distinguish the atrium from the ventricle and establish the atrial working myocardium. Single-cell transcriptomic analyses of the human heart have resolved distinct atrial and ventricular cardiomyocyte populations, confirming that chamber-specific gene programs are established and maintained in the mature organ.
Sarcomeric assembly and contractile maturation
In simple terms: Atrial cells build the tiny molecular motors that let them contract and pump blood.
As atrial cardiomyocytes mature, they assemble sarcomeres containing chamber-enriched myosin heavy chain isoforms such as MYH6, enabling striated contraction characteristic of cardiac muscle. The contractile apparatus of atrial cells is supported by structural proteins including obscurin, whose Ig58/59 domains contribute to atrial structural integrity and calcium-based signaling. Proper sarcomeric assembly is required for the mechanical function of the atrium as a blood-receiving chamber.
Electrical maturation and ion channel expression
In simple terms: Atrial cells develop the electrical wiring that controls their heartbeat rhythm.
Atrial cardiomyocytes acquire a distinct electrophysiological profile through the expression of chamber-specific ion channels, including KCNJ3 (GIRK1) and other channels that shape the atrial action potential. Atrial fibrillation-associated electrical remodeling in human induced pluripotent stem cell-derived atrial cardiomyocytes demonstrates that these cells recapitulate key atrial electrophysiological features and can be used to study arrhythmia mechanisms. Electrical maturation is essential for coordinated atrial contraction and for maintaining sinus rhythm.
Endocrine maturation and natriuretic peptide secretion
In simple terms: Atrial cells learn to release hormones that help control blood pressure and fluid balance.
A hallmark of mature atrial cardiomyocytes is the synthesis and secretion of cardiac natriuretic peptides, including NPPA and NPPB, which regulate blood volume, pressure, and sodium balance. Cardiac natriuretic peptides are established biomarkers and bioactive hormones whose production depends on the differentiated state of atrial cardiomyocytes. This endocrine function distinguishes atrial from ventricular cardiomyocytes and is a key endpoint of atrial cardiac muscle cell development.
Maintenance, remodeling, and disease susceptibility
In simple terms: Even after atrial cells mature, they can change in response to stress, which can lead to heart rhythm problems.
Mature atrial cardiomyocytes are not static; they undergo remodeling in response to hemodynamic, inflammatory, and metabolic stress, which can impair atrial function and promote arrhythmogenesis. Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis, linking inflammatory cell death pathways to atrial electrical instability. GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis, and PCSK9 inhibition with evolocumab prevents atrial fibrillation in rheumatoid arthritis rats, illustrating diverse molecular pathways that modulate atrial remodeling. Constitutive deletion of the obscurin-Ig58/59 domains induces atrial remodeling and Ca2+-based arrhythmogenesis, further demonstrating that structural and calcium-handling proteins are critical for maintaining mature atrial cardiomyocyte function.
Key Genes Involved in GO:0055014 atrial cardiac muscle cell development
The following genes and proteins are representative of the transcriptional, structural, electrical, and endocrine programs that define atrial cardiac muscle cell development and its maintenance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TBX5 | Chamber-specific transcription factor important for atrial identity and conduction | Studied in atrial development and arrhythmia models |
| NR2F2 | Transcription factor contributing to atrial chamber specification | Investigated in atrial chamber formation |
| PITX2 | Transcription factor associated with atrial laterality and arrhythmia susceptibility | Commonly studied in atrial fibrillation genetics |
| NPPA | Atrial natriuretic peptide precursor; endocrine marker of mature atrial cardiomyocytes | Used as a marker of atrial maturation and function |
| NPPB | Brain natriuretic peptide precursor; cardiac endocrine hormone | Biomarker and functional readout of atrial cardiomyocytes |
| MYH6 | Atrial-enriched myosin heavy chain; sarcomeric contractile protein | Marker of atrial contractile maturation |
| MYH7 | Myosin heavy chain isoform with chamber-specific expression | Studied in cardiac development and disease |
| KCNJ3 | G-protein-activated inwardly rectifying potassium channel subunit | Key to atrial action potential and electrical remodeling |
| GSDMD | Gasdermin D; mediator of pyroptosis and inflammation | Atrial cardiomyocyte-restricted cleavage promotes arrhythmogenesis |
| GSTP1 | Glutathione S-transferase P1; regulator of oxidative stress and ferroptosis | Inhibits angiotensin II-induced atrial fibrillation |
| PCSK9 | Proprotein convertase subtilisin/kexin type 9; lipid regulator | Inhibition prevents atrial fibrillation in rheumatoid arthritis rats |
| OBSCN | Obscurin; sarcomeric structural protein with Ig domains | Deletion of Ig58/59 domains induces atrial remodeling |
| TNNT2 | Cardiac troponin T; sarcomeric regulatory protein | General cardiac contractile marker |
| ACTC1 | Cardiac actin; core sarcomeric component | Marker of cardiomyocyte maturation |
| GJA1 | Connexin 43; gap junction protein for electrical coupling | Studied in cardiac conduction and remodeling |
| SCN5A | Voltage-gated sodium channel; cardiac excitability | Relevant to atrial electrophysiology |
| HCN4 | Hyperpolarization-activated cyclic nucleotide-gated channel | Marker of pacemaker-like cells and atrial conduction |
How Is atrial cardiac muscle cell development Regulated?
Atrial cardiac muscle cell development and maintenance are regulated by a combination of chamber-specific transcription factors, signaling pathways, and stress-responsive programs. Transcription factors such as TBX5, NR2F2, and PITX2 establish and maintain atrial identity, while natriuretic peptide genes NPPA and NPPB serve as readouts of the differentiated endocrine state. Inflammatory and cell death pathways, including gasdermin D-mediated pyroptosis, can disrupt atrial homeostasis and promote arrhythmogenesis. Oxidative stress and ferroptosis are modulated by GSTP1, which inhibits angiotensin II-induced atrial fibrillation, and lipid-related signaling through PCSK9 influences atrial remodeling in inflammatory conditions. Structural proteins such as obscurin contribute to calcium handling and electrical stability, and their loss leads to atrial remodeling and Ca2+-based arrhythmogenesis. Together, these regulatory layers determine whether atrial cardiomyocytes maintain a mature, electrically stable phenotype or transition toward a pro-arrhythmic state.
atrial cardiac muscle cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GSDMD | Atrial arrhythmogenesis via pyroptosis | Atrial cardiomyocyte-specific knockout or cleavage-resistant knock-in |
| GSTP1 | Angiotensin II-induced atrial fibrillation and ferroptosis | GSTP1 overexpression or knockout in atrial cells |
| PCSK9 | Atrial remodeling in rheumatoid arthritis-associated atrial fibrillation | PCSK9 inhibition or knockout in rat models |
| OBSCN | Atrial remodeling and Ca2+-based arrhythmogenesis | Obscurin-Ig58/59 domain deletion knock-in or knockout |
| PITX2 | Atrial fibrillation susceptibility | Point mutation or knockout in iPSC-derived atrial cardiomyocytes |
Atrial fibrillation and electrical remodeling
Atrial fibrillation is the most common sustained arrhythmia and is closely linked to abnormalities in atrial cardiomyocyte development and maintenance. Human induced pluripotent stem cell-derived atrial cardiomyocytes have been used to model atrial fibrillation-associated electrical remodeling, revealing a novel pathway for antiarrhythmic therapy development. Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis, linking inflammatory cell death to electrical instability. These findings indicate that genes governing atrial cardiomyocyte identity and survival are directly relevant to atrial fibrillation pathogenesis.
Inflammatory and metabolic contributions to atrial remodeling
Inflammatory and metabolic pathways can drive atrial remodeling and increase susceptibility to atrial fibrillation. GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis, highlighting a role for oxidative stress and iron-dependent cell death in atrial pathology. In rheumatoid arthritis rats, inhibition of PCSK9 with evolocumab prevents atrial fibrillation through restraint of PCSK9-induced atrial remodeling, connecting lipid metabolism and inflammation to atrial arrhythmogenesis. These studies demonstrate that atrial cardiomyocyte health depends on balanced inflammatory and metabolic signaling.
Structural and calcium-handling defects in atrial arrhythmogenesis
Structural proteins and calcium-handling machinery are essential for mature atrial cardiomyocyte function. Constitutive deletion of the obscurin-Ig58/59 domains induces atrial remodeling and Ca2+-based arrhythmogenesis, showing that sarcomeric integrity is required for atrial electrical stability. Because atrial cardiomyocytes rely on precise calcium cycling for contraction and relaxation, defects in these pathways can promote arrhythmias and impair atrial function. This underscores the importance of structural and calcium regulatory genes in atrial cardiac muscle cell development and disease.
Chamber-specific diversity and therapeutic implications
Single-cell transcriptomic studies have revealed substantial transcriptional and cellular diversity within the human heart, including chamber-specific cardiomyocyte populations. This diversity has therapeutic implications: atrial-selective targets may allow treatment of atrial arrhythmias while minimizing effects on ventricular function. Understanding the developmental programs that establish atrial identity is therefore critical for designing chamber-specific interventions.
From atrial cardiac muscle cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene control atrial chamber identity? | Knockout of transcription factor in iPSC-derived atrial cardiomyocytes |
| Does a variant alter atrial electrical properties? | Point mutation knock-in in iPSC-derived atrial cardiomyocytes |
| Does a gene product localize to atrial sarcomeres? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a protective gene prevent atrial remodeling? | Overexpression of GSTP1 or PCSK9 inhibitor in atrial cells or animal models |
| Does inflammatory cell death drive atrial arrhythmia? | Atrial cardiomyocyte-restricted knockout of GSDMD |
| Does loss of a structural protein cause atrial calcium defects? | Constitutive deletion of obscurin-Ig58/59 domains |
How to Study the atrial cardiac muscle cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Cell-type-specific transcriptomes | Resolving atrial vs ventricular cardiomyocyte diversity |
| Spatial transcriptomics | Gene expression with spatial context | Mapping atrial chamber organization |
| Patch-clamp electrophysiology | Ion channel function and action potentials | Assessing atrial electrical remodeling |
| Calcium imaging | Intracellular calcium transients | Detecting Ca2+-based arrhythmogenesis |
| CRISPR knockout | Loss-of-function phenotypes | Testing causal roles of atrial genes |
| CRISPR knock-in | Tagged or mutant protein expression | Localizing sarcomeric proteins |
| Natriuretic peptide ELISA | NPPA/NPPB secretion | Measuring atrial endocrine maturation |
| Immunofluorescence | Protein localization and sarcomere structure | Evaluating atrial structural integrity |
Single-cell and spatial transcriptomics
Single-cell RNA sequencing and spatial transcriptomics have been used to resolve the transcriptional and cellular diversity of the human heart, including chamber-specific atrial and ventricular cardiomyocyte populations. These methods allow researchers to identify atrial identity genes, maturation markers, and disease-associated expression changes at cellular resolution. They are particularly valuable for comparing atrial cardiomyocytes derived from human induced pluripotent stem cells with primary atrial tissue.
Electrophysiological and calcium imaging
Patch-clamp electrophysiology and calcium imaging are used to assess the electrical maturation and arrhythmia susceptibility of atrial cardiomyocytes. Human induced pluripotent stem cell-derived atrial cardiomyocytes have been employed to model atrial fibrillation-associated electrical remodeling and to test antiarrhythmic strategies. Calcium-based arrhythmogenesis can be studied in models with structural protein deletions, such as obscurin-Ig58/59 domain knockout.
CRISPR-based genetic perturbation
CRISPR-Cas9 knockout, point mutation, knock-in, and overexpression approaches enable causal testing of candidate genes in atrial cardiac muscle cell development. Atrial cardiomyocyte-restricted cleavage of gasdermin D was linked to arrhythmogenesis using genetic models, and GSTP1 and PCSK9 pathways have been manipulated to study atrial fibrillation mechanisms. These tools allow precise dissection of gene function in chamber-specific contexts.
Biochemical and histological assays
Biochemical assays for natriuretic peptides, sarcomeric proteins, and inflammatory markers provide functional readouts of atrial cardiomyocyte maturation and remodeling. Histological and immunofluorescence analyses can assess sarcomeric organization, gap junction distribution, and structural integrity in atrial tissue. These methods complement transcriptomic and electrophysiological approaches to provide a multi-layered view of atrial development and disease.
How CRISPR Can Be Used to Study GO:0055014 atrial cardiac muscle cell development
Knockout
CRISPR knockout is used to eliminate candidate genes and assess their requirement for atrial cardiac muscle cell development and function. For example, atrial cardiomyocyte-restricted deletion of GSDMD has been used to test the role of pyroptosis in atrial arrhythmogenesis, and knockout of GSTP1 or PCSK9-related pathways has been applied to study atrial fibrillation mechanisms. Knockout models are essential for determining whether a gene is necessary for atrial identity, electrical stability, or endocrine function.
Point Mutation
CRISPR point mutation introduces specific nucleotide changes to model disease-associated variants or to disrupt functional domains. This approach is valuable for studying atrial fibrillation-associated variants in genes such as PITX2 or ion channel genes, and for dissecting domain-specific functions of structural proteins like obscurin. Point mutation models allow precise genotype-phenotype correlation in atrial cardiomyocytes.
Knock-in
CRISPR knock-in enables the insertion of tags, reporters, or humanized sequences at endogenous loci. Tagged knock-in of sarcomeric or calcium-handling proteins can reveal their localization and dynamics in atrial cardiomyocytes. Knock-in of disease-relevant mutations in iPSC-derived atrial cardiomyocytes provides a platform for modeling atrial arrhythmias and testing therapeutics.
Overexpression
CRISPR-mediated overexpression or transgenic overexpression is used to test whether increased levels of a gene product protect against or promote atrial remodeling. Overexpression of GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis, and inhibition of PCSK9 via evolocumab prevents atrial fibrillation in rheumatoid arthritis rats. Overexpression models are useful for validating protective pathways and for identifying therapeutic targets in atrial disease.
How EDITGENE Supports atrial cardiac muscle cell development Research
Researchers studying atrial cardiac muscle cell development-related genes often need to determine whether a candidate gene is causally involved in atrial specification, maturation, or arrhythmogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional dissection of atrial genes in relevant cellular and animal systems.
Contact EDITGENE today to design your custom CRISPR model for atrial cardiac muscle cell development research.
Frequently Asked Questions About atrial cardiac muscle cell development
What is GO:0055014 atrial cardiac muscle cell development?
GO:0055014 is a Gene Ontology biological process term describing the progression of an atrial cardiac muscle cell over time, from its formation to the mature state, including the acquisition of atrial-specific contractile, electrical, and endocrine properties.
What genes are involved in atrial cardiac muscle cell development?
Key genes include TBX5, NR2F2, PITX2, NPPA, NPPB, MYH6, KCNJ3, GSDMD, GSTP1, PCSK9, and OBSCN, which contribute to atrial identity, contraction, electrical function, and endocrine secretion.
Why is atrial cardiac muscle cell development important?
It establishes the atrial chamber's ability to receive blood and secrete natriuretic peptides, and its disruption is linked to atrial fibrillation, electrical remodeling, and arrhythmogenesis.
How is atrial cardiac muscle cell development studied?
Researchers use single-cell transcriptomics, electrophysiology, calcium imaging, CRISPR-based genetic perturbation, and biochemical assays for natriuretic peptides and sarcomeric proteins.
What diseases are associated with defects in atrial cardiac muscle cell development?
Atrial fibrillation, atrial remodeling, and Ca2+-based arrhythmogenesis are associated with abnormalities in atrial cardiomyocyte development and maintenance.
Can human iPSC-derived atrial cardiomyocytes model atrial development?
Yes, human induced pluripotent stem cell-derived atrial cardiomyocytes recapitulate key atrial electrophysiological features and have been used to model atrial fibrillation-associated electrical remodeling.
What is the role of GSDMD in atrial arrhythmogenesis?
Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis, linking inflammatory cell death to atrial electrical instability.
How does GSTP1 affect atrial fibrillation?
GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis, indicating a protective role against oxidative stress-mediated atrial remodeling.
What is the link between PCSK9 and atrial fibrillation?
Inhibition of PCSK9 with evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9-induced atrial remodeling.
How does obscurin contribute to atrial function?
Constitutive deletion of the obscurin-Ig58/59 domains induces atrial remodeling and Ca2+-based arrhythmogenesis, showing that obscurin is required for atrial structural and electrical stability.
Conclusion
GO:0055014 atrial cardiac muscle cell development encompasses the specification, maturation, and maintenance of atrial cardiomyocytes, a process essential for normal atrial contraction, electrical stability, and endocrine function. Disruption of this process is linked to atrial fibrillation, atrial remodeling, and arrhythmogenesis through diverse molecular pathways involving inflammation, oxidative stress, lipid metabolism, and structural proteins. Advances in single-cell transcriptomics and human iPSC-derived atrial cardiomyocyte models, combined with CRISPR-based genetic tools, provide powerful approaches to dissect the causal roles of individual genes in atrial development and disease. Continued research into the regulatory networks governing atrial identity will inform chamber-specific therapeutic strategies for atrial arrhythmias and related cardiovascular conditions.
References
- 1. Goetze JP et al.. 2020. Cardiac natriuretic peptides.. Nat Rev Cardiol 17(11):698-717 PMID: 32444692
- 2. Tucker NR et al.. 2020. Transcriptional and Cellular Diversity of the Human Heart.. Circulation 142(5):466-482 PMID: 32403949
- 3. Seibertz F et al.. 2023. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.. Cardiovasc Res 119(16):2623-2637 PMID: 37677054
- 4. Yuan Y et al.. 2025. Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis.. Eur Heart J 46(13):1250-1262 PMID: 39927987
- 5. Li H et al.. 2025. GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis.. Europace 27(5) PMID: 40186487
- 6. Han X et al.. 2024. Evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9 induced atrial remodeling.. J Adv Res 61:211-221 PMID: 37709197
- 7. Grogan A et al.. 2025. Constitutive deletion of the obscurin-Ig58/59 domains induces atrial remodeling and Ca2+-based arrhythmogenesis.. JCI Insight 10(4) PMID: 39804820
- 8. Albu M et al.. 2025. Recent insights into atrial chamber formation.. Semin Cell Dev Biol 175:103664 PMID: 41265173
